• 1
    Walsh LJ. Serious complications of endodontic infections: some cautionary tales. Aust Dent J 1997;42:156159.
  • 2
    Bishay N, Petrikowski CG, Maxymiw WG, Lee L, Wood RE. Optimum dental radiography in bone marrow transplant patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:375379.
  • 3
    Donker AE, Van Merkesteyn JP, Bredius RG, Van Weel-Sipman MH. Value of panoramic radiographs in paediatric pre-bone marrow transplantation oral evaluation. Int J Oral Maxillofac Surg 2002;31:170172.
  • 4
    Wynne SE, Walsh LJ, Seymour GJ. Specialized postcapillary venules in human gingival tissue. J Periodontol 1988;59:328331.
  • 5
    Davies RM, Ellwood RP, Davies GM. The effectiveness of a toothpaste containing triclosan and polyvinyl-methyl ether maleic acid copolymer in improving plaque control and gingival health: a systematic review. J Clin Periodontol 2004;31:10291033.
  • 6
    Gunsolley JC. A meta-analysis of six-month studies of antiplaque and antigingivitis agents. J Am Dent Assoc 2006;137:16491657.
  • 7
    Blinkhorn A, Bartold PM, Cullinan MP, et al. Is there a role for triclosan/copolymer toothpaste in the management of periodontal disease? Br Dent J 2009;207:117125.
  • 8
    Reynolds EC. Calcium phosphate-based remineralization systems: scientific evidence? Aust Dent J 2008;53:268273.
  • 9
    Llena C, Forner L, Baca P. Anticariogenicity of casein phosphopeptide-amorphous calcium phosphate: a review of the literature. J Contemp Dent Pract 2009;10:19.
  • 10
    Neuhaus KW, Lussi A. Casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) and its effect on dental hard tissues. Schweiz Monatsschr Zahnmed 2009;119:110116.
  • 11
    Cross KJ, Huq NL, Reynolds EC. Casein phosphopeptides in oral health–chemistry and clinical applications. Curr Pharm Des 2007;13:793800.
  • 12
    Scully C, Epstein JB. Oral health care for the cancer patient. Eur J Cancer B Oral Oncol 1996;32B:281292.
  • 13
    Athanassiadis B, Abbott PV, Walsh LJ. The use of calcium hydroxide, antibiotics and biocides as antimicrobial medicaments in endodontics. Aust Dent J 2007;52(Suppl):S64S82.
  • 14
    Andrews N, Griffiths C. Dental complications of head and neck radiotherapy: Part 1. Aust Dent J 2001;46:8894.
  • 15
    Andrews N, Griffiths C. Dental complications of head and neck radiotherapy: Part 2. Aust Dent J 2001;46:174182.
  • 16
    Kanatas AN, Rogers SN, Martin MV. A practical guide for patients undergoing exodontia following radiotherapy to the oral cavity. Dent Update 2002;29:498503.
  • 17
    Koga DH, Salvajoli JV, Alves FA. Dental extractions and radiotherapy in head and neck oncology: review of the literature. Oral Dis 2008;14:4044.
  • 18
    Teng MS, Futran ND. Osteoradionecrosis of the mandible. Curr Opin Otolaryngol Head Neck Surg 2005;13:217221.
  • 19
    Jereczek-Fossa BA, Orecchia R. Radiotherapy-induced mandibular bone complications. Cancer Treat Rev 2002;28:6574.
  • 20
    Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 2003;14:199212.
  • 21
    Kielbassa AM, Hinkelbein W, Hellwig E, Meyer-Lückel H. Radiation-related damage to dentition. Lancet Oncol 2006;7:326335.
  • 22
    Walsh LJ, Hill G, Seymour G, Roberts A. A scoring system for the quantitative evaluation of oral mucositis during bone marrow transplantation. Spec Care Dentist 1990;10:190195.
  • 23
    Walsh LJ, Athanasas-Platsis S, Savage NW. Reconstitution of cutaneous neural-immunological networks following bone marrow transplantation. Transplantation 1996;61:413417.
  • 24
    Egan CL, Viglione-Schneck MJ, Walsh LJ, et al. Characterization of unmyelinated axons uniting epidermal and dermal immune cells in primate and murine skin. J Cutan Pathol 1998;25:2029.
  • 25
    Pattni R, Walsh LJ, Marshall RI, Cullinan MP, Seymour GJ, Bartold PM. Changes in the periodontal status of patients undergoing bone marrow transplantation. J Periodontol 2000;71:394402.
  • 26
    Sawyer HE, Smith ASA, Walsh LJ. Acute gingival pathology following bone marrow transplantation. Periodontol 1997;18:3945.
  • 27
    Quirk PC, Osborne PJ, Walsh LJ. Efficacy of antifungal prophylaxis in bone marrow transplantation. Aust Dent J 1995;40:267270.
  • 28
    Pattni R, Walsh LJ, Marshall RI, Seymour GJ, Bartold PM. Periodontal manifestations of immunodeficient states: manifestations and management. J Int Acad Periodont 2000;2:7993.
  • 29
    Furumoto EK, Barker GJ, Carter-Hanson C, Barker BF. Subjective and clinical evaluation of oral lubricants in xerostomic patients. Spec Care Dentist 1998;18:113118.
  • 30
    Walsh LJ. Salivary dysfunction: management approaches for the dry mouth patient. Hygiene Today 2001;11:47.
  • 31
    Walsh LJ. Clinical aspects of salivary biology for the dental clinician. Internat Dent SA (Australas Edn) 2007;2:1630.
  • 32
    Hay KD, Morton RP. The efficacy of casein phosphoprotein-calcium phosphate complex (DC-CP) [Dentacal] as a mouth moistener in patients with severe xerostomia. N Z Dent J 2003;99:4648.
  • 33
    Bernardi F, Pincelli MR, Carloni S, Gatto MR, Montebugnoli L. Chlorhexidine with an anti-discoloration system. A comparative study. Int J Dent Hyg 2004;2:122126.
  • 34
    Winer RA, Chauncey HH, Garcia RI. Effect of Peroxyl mouthrinse on chlorhexidine staining of teeth. J Clin Dent 1991; 3:1518.
  • 35
    Kolahi J, Soolari A. Rinsing with chlorhexidine gluconate solution after brushing and flossing teeth: a systematic review of effectiveness. Quintessence Int 2006;37:605612.
  • 36
    Stokman MA, Spijkervet FK, Burlage FR, Dijkstra PU, Manson WL, De Vries EG, Roodenburg JL. Oral mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial. Br J Cancer 2003;88:10121016.
  • 37
    Stokman MA, Spijkervet FK, Boezen HM, Schouten JP, Roodenburg JL, De Vries EG. Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses. J Dent Res 2006;85:690700.
  • 38
    Von Bültzingslöwen I, Brennan MT, Spijkervet FK, et al. Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis. Support Care Cancer 2006;14:519527.
  • 39
    Peterson DE, Cariello A. Mucosal damage: a major risk factor for severe complications after cytotoxic therapy. Semin Oncol 2004;31(3 Suppl 8):3544.
  • 40
    Keefe DM, Sonis ST, Bowen JM. Emerging drugs for chemotherapy-induced mucositis. Expert Opin Emerg Drugs 2008;13:511522.
  • 41
    Spielberger R, Stiff P, Bensinger W, et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004;351:25902598.
  • 42
    Keefe DM, Schubert MM, Elting LS, et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 2007;109:820831.
  • 43
    Simões A, Nicolau J, De Souza DN, et al. Effect of defocused infrared diode laser on salivary flow rate and some salivary parameters of rats. Clin Oral Investig 2008;12:2530.
  • 44
    Plavnik LM, De Crosa ME, Malberti AI. Effect of low-power radiation (helium/neon) upon submandibulary glands. J Clin Laser Med Surg 2003;21:219225.
  • 45
    Takeda Y. Irradiation effect of low-energy laser on rat submandibular salivary gland. J Oral Pathol 1988;17:9194.
  • 46
    Barasch A, Peterson DE, Tanzer JM, et al. Helium-neon laser effects on conditioning-induced oral mucositis in bone marrow transplantation patients. Cancer 1995;76:25502556.
  • 47
    Bensadoun RJ, Franquin JC, Ciais G, et al. Low-energy He/Ne laser in the prevention of radiation-induced mucositis. A multicenter phase III randomized study in patients with head and neck cancer. Support Care Cancer 1999;7:244252.
  • 48
    Wong SF, Wilder-Smith P. Pilot study of laser effects on oral mucositis in patients receiving chemotherapy. Cancer J 2002;8:247254.
  • 49
    Genot MT, Klastersky J. Low-level laser for prevention and therapy of oral mucositis induced by chemotherapy or radiotherapy. Curr Opin Oncol 2005;17:236240.
  • 50
    Arun Maiya G, Sagar MS, Fernandes D. Effect of low level helium-neon (He-Ne) laser therapy in the prevention and treatment of radiation induced mucositis in head and neck cancer patients. Indian J Med Res 2006;124:399402.
  • 51
    Cruz LB, Ribeiro AS, Rech A, Rosa LG, Castro CG Jr, Brunetto AL. Influence of low-energy laser in the prevention of oral mucositis in children with cancer receiving chemotherapy. Pediatr Blood Cancer 2007;48:435440.
  • 52
    Abramoff MM, Lopes NN, Lopes LA, et al. Low-level laser therapy in the prevention and treatment of chemotherapy-induced oral mucositis in young patients. Photomed Laser Surg 2008;26:393400.
  • 53
    Genot-Klastersky MT, Klastersky J, Awada F, et al. The use of low-energy laser (LEL) for the prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studies. Support Care Cancer 2008;16:13811387.
  • 54
    Simões A, Eduardo FP, Luiz AC, et al. Laser phototherapy as topical prophylaxis against head and neck cancer radiotherapy-induced oral mucositis: comparison between low and high/low power lasers. Lasers Surg Med 2009;41:264270.
  • 55
    Elting LS, Cooksley CD, Chambers MS, Garden AS. Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies. Int J Radiat Oncol Biol Phys 2007;68:11101120.
  • 56
    Murphy BA. Clinical and economic consequences of mucositis induced by chemotherapy and/or radiation therapy. J Support Oncol 2007;5(9 Suppl 4):1321.
  • 57
    Dodd MJ, Miaskowski C, Greenspan D, et al. Radiation-induced mucositis: a randomized clinical trial of micronized sucralfate versus salt and soda mouthwashes. Cancer Invest 2003;21:2133.
  • 58
    Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dent Clin North Am 2008;52:6177.
  • 59
    Worthington HV, Clarkson JE, Eden OB. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 2007;4:CD000978.
  • 60
    Walsh LJ. Preventive dentistry for the medically compromised patient. Dent Today 1992;8:17.
  • 61
    Walsh LJ. Preventive dentistry for the general dental practitioner. Aust Dent J 2000;45:7682.
  • 62
    Walsh LJ. Preventive dentistry. Brisbane: Knowledge Books and Software, 2001.
  • 63
    Reynolds EC, Walsh LJ. Additional aids to the remineralization of tooth structure. In: MountGJ, HumeWR, eds. Preservation and restoration of teeth. 2nd edn. Brisbane: Knowledge Books and Software, 2005:111118.
  • 64
    Walsh LJ. Tooth mousse: anthology of applications. GC Asia Dental, Singapore. 2007.
  • 65
    Walsh LJ. A system for total environmental management (STEM) of the oral cavity, and its application to dental caries control. Internat Dent SA (Australas Edn) 2008;3:3448.
  • 66
    Cockings JM, Savage NW, Walsh LJ. Genetic factors in cyclosporin-induced gingival overgrowth. Periodontol 1998;19:9297.
  • 67
    Walsh LJ, Sugerman PB, Durrant ST. Long-term oral soft and hard tissue changes following BMT. Bone Marrow Transplant 1993;11(Suppl 1):108.
  • 68
    Sawyer HE, Smith ASA, Walsh LJ. Acute gingival pathology following bone marrow transplantation. Periodontol 1997;18:3945.
  • 69
    Walsh LJ. Dental plaque fermentation and its role in caries risk assessment. Internat Dent (Australas Edn) 2006;1:413.